DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020705
The generic ingredient in RESCRIPTOR is delavirdine mesylate. One supplier is listed for this compound. Additional details are available on the delavirdine mesylate profile page.
Summary for 020705
Tradename: | RESCRIPTOR |
Applicant: | Viiv Hlthcare |
Ingredient: | delavirdine mesylate |
Patents: | 1 |
Therapeutic Class: | Antivirals |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 020705
Ingredient-type | Non-Nucleoside Analog |
Mechanism of Action | Non-Nucleoside Reverse Transcriptase Inhibitors |
Medical Subject Heading (MeSH) Categories for 020705
Suppliers and Packaging for NDA: 020705
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705 | NDA | ViiV Healthcare Company | 49702-209 | N | 49702-209-24 |
RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705 | NDA | ViiV Healthcare Company | 49702-225 | N | 49702-225-17 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Apr 4, 1997 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Jul 14, 1999 | TE: | RLD: | Yes | |||||
Patent: | ➤ Try a Free Trial | Patent Expiration: | Jun 7, 2019 | Product Flag? | Substance Flag? | Delist Request? |
Expired US Patents for NDA 020705
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-001 | Apr 4, 1997 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Viiv Hlthcare | RESCRIPTOR | delavirdine mesylate | TABLET;ORAL | 020705-002 | Jul 14, 1999 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription